Cross Border Impact Ventures
Overview
Cross-Border Impact Ventures is an impact venture capital firm on a mission to revolutionize venture investing in health technology. They invest in world class, early-growth stage health technology companies commercializing medical devices, diagnostics, therapeutics, and digital health innovations that benefit women, children and adolescents. The firm targets venture returns for its investors and empower its portfolio companies to reach beyond their primary markets in the United States and Europe to reach more vulnerable populations in emerging markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pendulum Therapeutics | Feb 2025 | Seed | Co-investor |
| OncoLens | Oct 2024 | Series B | Lead |
| Bactolife | Jan 2026 | Series B | Lead |
| Daye | Oct 2022 | Series A | Co-investor |
| TidalSense | Jul 2026 | Early Funding | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cross Border Impact Ventures based?
Cross Border Impact Ventures is headquartered in Toronto, Ontario, Canada.
When was Cross Border Impact Ventures founded?
Cross Border Impact Ventures was founded in 2019.
How many portfolio companies does Cross Border Impact Ventures have?
Cross Border Impact Ventures has 11 portfolio companies in Caplight's dataset.
What are some companies in Cross Border Impact Ventures's portfolio?
Portfolio companies visible on Caplight include Pendulum Therapeutics, OncoLens, Bactolife, Daye, TidalSense.
What was Cross Border Impact Ventures's most recent investment shown here?
Cross Border Impact Ventures's most recent investment in this portfolio sample was in TidalSense in 2026.
What sectors does Cross Border Impact Ventures focus on?
Cross Border Impact Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce, AI, Data & Cloud Infrastructure, Consumer & Commerce, Enterprise Software, Consumer & Commerce.
What company stages does Cross Border Impact Ventures focus on?
Cross Border Impact Ventures typically invests at the Early stage.
What is Cross Border Impact Ventures's AUM?
Cross Border Impact Ventures's assets under management are estimated between $50.0M and $100.0M.